Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development

Overview

Journal Front Genet

Date 2020 May 5

PMID 32362913

Citations 19

Authors

Ida Larsson

Mathias Uhlen

Cheng Zhang

Adil Mardinoglu

Affiliations

Soon will be listed here.

Abstract

Glioblastoma (GBM) is an aggressive type of brain cancer with a poor prognosis for affected patients. The current line of treatment only gives the patients a survival time of on average 15 months. In this work, we use genome-scale metabolic models (GEMs) together with other systems biology tools to examine the global transcriptomics-data of GBM-patients obtained from The Cancer Genome Atlas (TCGA). We reveal the molecular mechanisms underlying GBM and identify potential therapeutic targets for effective treatment of patients. The work presented consists of two main parts. The first part stratifies the patients into two groups, high and low survival, and compares their gene expression. The second part uses GBM and healthy brain tissue GEMs to simulate gene knockout in a GBM cell model to find potential therapeutic targets and predict their side effect in healthy brain tissue. We (1) find that genes upregulated in the patients with low survival are linked to various stages of the glioma invasion process, and (2) identify five essential genes for GBM, whose inhibition is non-toxic to healthy brain tissue, therefore promising to investigate further as therapeutic targets.

Citing Articles

Boric acid impedes glioblastoma growth in a rat model: insights from multi-approach analysis.

Turkez H, Alper F, Bayram C, Baba C, Yildiz E, Saracoglu M Med Oncol. 2025; 42(2):47.

PMID: 39821858 PMC: 11742329. DOI: 10.1007/s12032-025-02600-z.

Integrating Molecular Perspectives: Strategies for Comprehensive Multi-Omics Integrative Data Analysis and Machine Learning Applications in Transcriptomics, Proteomics, and Metabolomics.

Sanches P, de Melo N, M Porcari A, de Carvalho L Biology (Basel). 2024; 13(11).

PMID: 39596803 PMC: 11592251. DOI: 10.3390/biology13110848.

Identifying Hub Genes and Metabolic Pathways in Collagen VI-Related Dystrophies: A Roadmap to Therapeutic Intervention.

Ceyhan A, Kaynar A, Altay O, Zhang C, Temel S, Turkez H Biomolecules. 2024; 14(11).

PMID: 39595553 PMC: 11592009. DOI: 10.3390/biom14111376.

Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based Approach.

Kaynar A, Kim W, Ceyhan A, Zhang C, Uhlen M, Turkez H Biomedicines. 2024; 12(10).

PMID: 39457550 PMC: 11504402. DOI: 10.3390/biomedicines12102237.

From Data to Cure: A Comprehensive Exploration of Multi-omics Data Analysis for Targeted Therapies.

Mukherjee A, Abraham S, Singh A, Balaji S, Mukunthan K Mol Biotechnol. 2024; .

PMID: 38565775 DOI: 10.1007/s12033-024-01133-6.

References

Mardinoglu A, Boren J, Smith U, Uhlen M, Nielsen J . Systems biology in hepatology: approaches and applications. Nat Rev Gastroenterol Hepatol. 2018; 15(6):365-377. DOI: 10.1038/s41575-018-0007-8. View

Pornputtapong N, Nookaew I, Nielsen J . Human metabolic atlas: an online resource for human metabolism. Database (Oxford). 2015; 2015:bav068. PMC: 4513696. DOI: 10.1093/database/bav068. View

Agren R, Mardinoglu A, Asplund A, Kampf C, Uhlen M, Nielsen J . Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol Syst Biol. 2014; 10:721. PMC: 4017677. DOI: 10.1002/msb.145122. View

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

Geng F, Guo D . Lipid droplets, potential biomarker and metabolic target in glioblastoma. Intern Med Rev (Wash D C). 2017; 3(5). PMC: 5639724. DOI: 10.18103/imr.v3i5.443. View

Cuddapah V, Robel S, Watkins S, Sontheimer H . A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 2014; 15(7):455-65. PMC: 5304245. DOI: 10.1038/nrn3765. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Uhlen M, Zhang C, Lee S, Sjostedt E, Fagerberg L, Bidkhori G . A pathology atlas of the human cancer transcriptome. Science. 2017; 357(6352). DOI: 10.1126/science.aan2507. View

10.

Chinnaiyan P, Kensicki E, Bloom G, Prabhu A, Sarcar B, Kahali S . The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res. 2012; 72(22):5878-88. PMC: 4638418. DOI: 10.1158/0008-5472.CAN-12-1572-T. View

11.

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

12.

Meyers R, Bryan J, McFarland J, Weir B, Sizemore A, Xu H . Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat Genet. 2017; 49(12):1779-1784. PMC: 5709193. DOI: 10.1038/ng.3984. View

13.

Hattingen E, Lanfermann H, Quick J, Franz K, Zanella F, Pilatus U . 1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours. MAGMA. 2008; 22(1):33-41. DOI: 10.1007/s10334-008-0145-z. View

14.

Chelliah V, Juty N, Ajmera I, Ali R, Dumousseau M, Glont M . BioModels: ten-year anniversary. Nucleic Acids Res. 2014; 43(Database issue):D542-8. PMC: 4383975. DOI: 10.1093/nar/gku1181. View

15.

Ostrom Q, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y . CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013; 15 Suppl 2:ii1-56. PMC: 3798196. DOI: 10.1093/neuonc/not151. View

16.

Lin H, Patel S, Affleck V, Wilson I, Turnbull D, Joshi A . Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells. Neuro Oncol. 2016; 19(1):43-54. PMC: 5193020. DOI: 10.1093/neuonc/now128. View

17.

Maarleveld T, Khandelwal R, Olivier B, Teusink B, Bruggeman F . Basic concepts and principles of stoichiometric modeling of metabolic networks. Biotechnol J. 2013; 8(9):997-1008. PMC: 4671265. DOI: 10.1002/biot.201200291. View

18.

Grossman R, Heath A, Ferretti V, Varmus H, Lowy D, Kibbe W . Toward a Shared Vision for Cancer Genomic Data. N Engl J Med. 2016; 375(12):1109-12. PMC: 6309165. DOI: 10.1056/NEJMp1607591. View

19.

Holland E . Glioblastoma multiforme: the terminator. Proc Natl Acad Sci U S A. 2000; 97(12):6242-4. PMC: 33993. DOI: 10.1073/pnas.97.12.6242. View

20.

Wirsching H, Galanis E, Weller M . Glioblastoma. Handb Clin Neurol. 2016; 134:381-97. DOI: 10.1016/B978-0-12-802997-8.00023-2. View